IL114784A - Benzoxazolyl-and benzothiazolyloxa-zolidinones stheir preparation and pharmaceutical compositions containing them - Google Patents
Benzoxazolyl-and benzothiazolyloxa-zolidinones stheir preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL114784A IL114784A IL11478495A IL11478495A IL114784A IL 114784 A IL114784 A IL 114784A IL 11478495 A IL11478495 A IL 11478495A IL 11478495 A IL11478495 A IL 11478495A IL 114784 A IL114784 A IL 114784A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- substd
- opt
- alkoxy
- acyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4427475 | 1994-08-03 | ||
DE19514313A DE19514313A1 (de) | 1994-08-03 | 1995-04-18 | Benzoxazolyl- und Benzothiazolyloxazolidinone |
Publications (2)
Publication Number | Publication Date |
---|---|
IL114784A0 IL114784A0 (en) | 1995-11-27 |
IL114784A true IL114784A (en) | 1999-10-28 |
Family
ID=25938925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11478495A IL114784A (en) | 1994-08-03 | 1995-07-31 | Benzoxazolyl-and benzothiazolyloxa-zolidinones stheir preparation and pharmaceutical compositions containing them |
Country Status (30)
Country | Link |
---|---|
US (1) | US5529998A (fr) |
EP (1) | EP0697412B1 (fr) |
JP (1) | JPH0881463A (fr) |
KR (1) | KR960007585A (fr) |
CN (1) | CN1122803A (fr) |
AT (1) | ATE188698T1 (fr) |
AU (1) | AU698939B2 (fr) |
BG (1) | BG62404B1 (fr) |
CA (1) | CA2155092A1 (fr) |
CO (1) | CO4410392A1 (fr) |
CZ (1) | CZ198895A3 (fr) |
DE (2) | DE19514313A1 (fr) |
DZ (1) | DZ1920A1 (fr) |
EE (1) | EE9500049A (fr) |
FI (1) | FI953665A (fr) |
HR (1) | HRP950428A2 (fr) |
HU (1) | HUT75037A (fr) |
IL (1) | IL114784A (fr) |
MA (1) | MA23638A1 (fr) |
NO (1) | NO305701B1 (fr) |
NZ (1) | NZ272674A (fr) |
PE (1) | PE2796A1 (fr) |
PL (1) | PL309848A1 (fr) |
RO (1) | RO115263B1 (fr) |
SK (1) | SK97495A3 (fr) |
SV (1) | SV1995000045A (fr) |
TN (1) | TNSN95088A1 (fr) |
TW (1) | TW352386B (fr) |
YU (1) | YU51095A (fr) |
ZA (1) | ZA956445B (fr) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP960159A2 (en) * | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
HRP970049A2 (en) | 1996-02-06 | 1998-04-30 | Bayer Ag | New heteroaryl oxazolidinones |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
GB9609919D0 (en) * | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9717807D0 (en) * | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
NZ505902A (en) | 1998-01-23 | 2003-08-29 | Upjohn Co | Oxazolidinone compounds useful as antimicrobial agents and combinatorial libraries |
EP1082323A2 (fr) | 1998-06-05 | 2001-03-14 | AstraZeneca UK Limited | Composes chimiques |
GB9815880D0 (en) | 1998-07-21 | 1998-09-16 | Pfizer Ltd | Heterocycles |
US6420349B1 (en) | 1998-08-24 | 2002-07-16 | Bristol-Myers Squibb Company | Isoxazolinone antibacterial agents |
WO2000029409A1 (fr) * | 1998-11-17 | 2000-05-25 | Bayer Aktiengesellschaft | Nouveaux derives d'oxazolidone substitues par un heterocyclyle |
JP2002535680A (ja) | 1999-01-27 | 2002-10-22 | ファルマシア・アンド・アップジョン・カンパニー | 延長因子p活性モジュレーターのアッセイ方法 |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
US6514529B2 (en) | 2000-03-22 | 2003-02-04 | Pharmacia & Upjohn Company | Oxazolidinone tablet formulation |
MY127336A (en) | 2000-03-22 | 2006-11-30 | Upjohn Co | Container for linezolid iv solution |
GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
US6465456B2 (en) | 2000-06-29 | 2002-10-15 | Bristol-Myers Squibb Company | Isoxazolinone antibacterial agents |
ATE301474T1 (de) | 2000-06-30 | 2005-08-15 | Pharmacia & Upjohn Co Llc | Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten |
ATE375983T1 (de) | 2000-12-15 | 2007-11-15 | Vertex Pharma | Bakterielle gyrase-hemmer und deren verwendung |
JP2004518677A (ja) | 2000-12-21 | 2004-06-24 | ファルマシア・アンド・アップジョン・カンパニー | 抗菌性キノロン誘導体および細菌感染を治療するためのその使用 |
AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
WO2003084534A1 (fr) * | 2002-03-29 | 2003-10-16 | Pharmacia & Upjohn Company Llc | Administration orale, parenterale ou intraveineuse d'oxazolidinones utilisees dans le traitement des infections du pied causees par le diabete |
DE60309701T2 (de) * | 2002-06-13 | 2007-09-06 | Vertex Pharmaceuticals Inc., Cambridge | 2-ureido-6-heteroaryl-3h-benzoimidazol-4-carbonsäurederivate und verwandte verbindungen als gyrase und/oder topoisomerase iv inhibitoren zur behandlung von bakteriellen infektionen |
JP2005537301A (ja) * | 2002-08-12 | 2005-12-08 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N−アリール−2−オキサゾリジノン類及びそれらの誘導体 |
AU2002339721A1 (en) * | 2002-09-20 | 2004-04-08 | Lupin Limited | Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents |
AR042086A1 (es) * | 2002-11-21 | 2005-06-08 | Upjohn Co | N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos |
US7582635B2 (en) | 2002-12-24 | 2009-09-01 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
US7569591B2 (en) * | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US8193352B2 (en) * | 2003-01-31 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7582641B2 (en) | 2003-01-31 | 2009-09-01 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7618974B2 (en) * | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
MXPA05007937A (es) * | 2003-02-07 | 2005-09-30 | Warner Lambert Co | Agentes antibacterianos. |
JP2006516991A (ja) * | 2003-02-07 | 2006-07-13 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 抗菌剤 |
US7012088B2 (en) * | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
US20040204463A1 (en) * | 2003-04-01 | 2004-10-14 | Harris Christina Renee | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
BRPI0413838A (pt) * | 2003-08-25 | 2006-10-24 | Warner Lambert Co | compostos de ariloxazolidinona antimicrobianos |
US7304050B2 (en) * | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
US20060004090A1 (en) * | 2004-07-01 | 2006-01-05 | Roberts William J | Forskolin compositions and methods for administration |
US20090221655A1 (en) * | 2006-02-01 | 2009-09-03 | Pitzer, Inc. | Antibacterial agents |
CN101460495B (zh) | 2006-03-31 | 2013-08-14 | 财团法人乙卯研究所 | 具有杂环的化合物 |
US8389549B2 (en) * | 2007-04-27 | 2013-03-05 | Purdue Pharma L.P. | Substituted pyridines useful for treating pain |
DK2142529T3 (da) | 2007-04-27 | 2014-02-10 | Purdue Pharma Lp | Trpv1-antagonister og anvendelser deraf |
EP2233484A3 (fr) | 2007-10-02 | 2012-04-04 | Research Foundation Itsuu Laboratory | Dérivés de oxazolidone ayant un cycle hétérocyclique à sept membre |
WO2009104159A1 (fr) * | 2008-02-22 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Dérivés d'oxazolidinone |
US8703962B2 (en) * | 2008-10-24 | 2014-04-22 | Purdue Pharma L.P. | Monocyclic compounds and their use as TRPV1 ligands |
US8759362B2 (en) * | 2008-10-24 | 2014-06-24 | Purdue Pharma L.P. | Bicycloheteroaryl compounds and their use as TRPV1 ligands |
SG191945A1 (en) | 2011-01-14 | 2013-08-30 | Vertex Pharma | Process of making gyrase and topoisomerase iv inhibitors |
MX341342B (es) | 2011-01-14 | 2016-08-17 | Vertex Pharma | Formas solidas del inhibidor de girasa (r)-1-etil-3-[6-fluoro-5-[2 -(1-hidroxi-1-metil-etil) pirimidin-5-il]-7-(tetrahidrofuran-2-il) -1h-benzimidazol-2-il]urea. |
EP2663558A1 (fr) | 2011-01-14 | 2013-11-20 | Vertex Pharmaceuticals Incorporated | Formes solides de l'inhibiteur de gyrase, la (r)-1-éthyl-3-[5-[2-{1-hydroxy-1-méthyl-éthyl}pyrimidin-5-yl]-7-(tétrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urée |
CN103443096B (zh) | 2011-01-14 | 2016-06-29 | 沃泰克斯药物股份有限公司 | 促旋酶和拓扑异构酶iv抑制剂 |
ES2576298T3 (es) | 2011-06-20 | 2016-07-06 | Vertex Pharmaceuticals Incorporated | Ésteres de fosfato de inhibidores de girasa y topoisomerasa |
EP2723732B1 (fr) | 2011-06-22 | 2017-01-18 | Purdue Pharma LP | Antagonistes de trpv1 comprenant un substituant dihydroxy et leurs utilisations |
US9394293B2 (en) | 2011-08-10 | 2016-07-19 | Purdue Pharma L.P. | TRPV1 antagonists including dihydroxy substituent and uses thereof |
US9018216B2 (en) | 2012-07-18 | 2015-04-28 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
WO2014014845A1 (fr) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Thérapie combinée comprenant de la 1-éthyl-3[5-[-2-{1-hydroxy-1-méthyl-éthyl}pyrimidin-5-yl]-7-(tétrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urée et ses dérivés pour traiter des maladies mycobactériennes |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4705799A (en) | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
GB8504871D0 (en) * | 1985-02-26 | 1985-03-27 | Ici Plc | Heterocyclic compounds |
US4921869A (en) | 1987-10-09 | 1990-05-01 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4801600A (en) | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4965268A (en) | 1987-10-09 | 1990-10-23 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
CA1320730C (fr) | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Derives d'aminomethyloxooxazolidinylaroylbenzene, agents antibacteriens |
US5254577A (en) | 1988-07-29 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
DE68929303T2 (de) * | 1988-09-15 | 2002-05-02 | Upjohn Co | 3-(Stickstoff substituierte)phenyl-5-beta-amidomethyloxazoliden-2-one |
JP2669579B2 (ja) | 1991-10-23 | 1997-10-29 | エーザイ株式会社 | オキサゾリドン誘導体 |
WO1993009103A1 (fr) * | 1991-11-01 | 1993-05-13 | The Upjohn Company | Aryl- et heteroarylphenyloxazolidinones substituees, utilisees comme agents antibacteriens |
-
1995
- 1995-04-18 DE DE19514313A patent/DE19514313A1/de not_active Withdrawn
- 1995-06-14 TN TNTNSN95088A patent/TNSN95088A1/fr unknown
- 1995-07-18 RO RO95-01322A patent/RO115263B1/ro unknown
- 1995-07-21 AT AT95111477T patent/ATE188698T1/de active
- 1995-07-21 DE DE59507595T patent/DE59507595D1/de not_active Expired - Fee Related
- 1995-07-21 EP EP95111477A patent/EP0697412B1/fr not_active Expired - Lifetime
- 1995-07-25 HR HR19514313.2A patent/HRP950428A2/hr not_active Application Discontinuation
- 1995-07-27 US US08/508,245 patent/US5529998A/en not_active Expired - Fee Related
- 1995-07-27 AU AU27230/95A patent/AU698939B2/en not_active Ceased
- 1995-07-28 SV SV1995000045A patent/SV1995000045A/es unknown
- 1995-07-28 JP JP7211265A patent/JPH0881463A/ja active Pending
- 1995-07-28 NZ NZ272674A patent/NZ272674A/en unknown
- 1995-07-31 CA CA002155092A patent/CA2155092A1/fr not_active Abandoned
- 1995-07-31 IL IL11478495A patent/IL114784A/xx active IP Right Grant
- 1995-08-01 BG BG99833A patent/BG62404B1/bg unknown
- 1995-08-01 FI FI953665A patent/FI953665A/fi unknown
- 1995-08-01 PL PL95309848A patent/PL309848A1/xx unknown
- 1995-08-02 KR KR1019950023799A patent/KR960007585A/ko not_active Application Discontinuation
- 1995-08-02 SK SK974-95A patent/SK97495A3/sk unknown
- 1995-08-02 EE EE9500049A patent/EE9500049A/xx unknown
- 1995-08-02 ZA ZA956445A patent/ZA956445B/xx unknown
- 1995-08-02 DZ DZ950098A patent/DZ1920A1/fr active
- 1995-08-02 NO NO953045A patent/NO305701B1/no unknown
- 1995-08-02 CZ CZ951988A patent/CZ198895A3/cs unknown
- 1995-08-02 PE PE1995275165A patent/PE2796A1/es not_active Application Discontinuation
- 1995-08-02 HU HU9502295A patent/HUT75037A/hu unknown
- 1995-08-03 TW TW084108069A patent/TW352386B/zh active
- 1995-08-03 MA MA23979A patent/MA23638A1/fr unknown
- 1995-08-03 CO CO95034777A patent/CO4410392A1/es unknown
- 1995-08-03 CN CN95115330A patent/CN1122803A/zh active Pending
- 1995-08-11 YU YU51095A patent/YU51095A/sh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL114784A (en) | Benzoxazolyl-and benzothiazolyloxa-zolidinones stheir preparation and pharmaceutical compositions containing them | |
BR9404831A (pt) | Composto,formulação farmacêutica e processo de preparação de um composto | |
DZ1467A1 (fr) | Dérivés d'acides amines. | |
NO305206B1 (no) | Oksazolidinonkarboksylsyrederivater, farmas°ytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
IL102361A0 (en) | Benzomorphan derivatives,their preparation and pharmaceutical compositions containing them | |
ZA955631B (en) | Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them | |
ATE196472T1 (de) | Antibiotische cephalosporine einen substituierten benzyloxyimino-radikal in position 7 tragend | |
IL120863A0 (en) | Sulfur-containing heterocyclic bradykinin antagonists process for their preparation and their use | |
IL119054A0 (en) | Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them | |
NO306991B1 (no) | Alkenylbenzoylguanidinderivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |